Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients

Fig. 3

Efficacy comparison of cisplatin combined with IL-2 versus cisplatin alone by thoracic injection for controlling MPE. a Thoracic injection of cisplatin alone had a higher NRR compared with cisplatin combined with IL-2 (pā€‰<ā€‰0.001). b Thoracic injection of cisplatin combined with IL-2 had a higher QOL compared with cisplatin alone (pā€‰<ā€‰0.001); NRR, non-response rate; QOL, quality of life; OR, odds ratio

Back to article page